Skip to main content

Main menu

  • About
    • Our Mission
    • Donors
    • Board of Directors
    • Advisory Boards
    • Staff
    • Careers
    • FAQ
    • Annual Report
  • Why New TB Drugs?
    • Global Pandemic
    • Inadequate Treatment
    • Antimicrobial Resistance
    • Maternal and Child Health
    • Cycle of Poverty
  • R&D
    • Scientific Vision
    • Pipeline
    • Discovery
    • Engaging Communities
  • Access
    • Our Commitment
    • Access in TB Market
    • Child-friendly medicines
    • Pretomanid and BPaL
    • Pathways to Access BPaL
  • News
    • Latest News
    • Publications
    • Voices of TB
    • Research Papers
    • Making an Impact
  • Donate

Search form

Latest News

May 17

TB Alliance receives up to $3.9M from the Cystic Fibrosis Foundation to further the development of an NTM drug

May 8

TB Alliance Statement on United Nations Multi-Stakeholder Hearing on Tuberculosis

March 10

Ratan P. Watal Appointed to the Board of TB Alliance

All News

Voices of TB

Videos from the Global Health Community

Besik's Story of #TBCourage

Fighting the Oldest Pandemic

All Voices

Featured Publication

Advancing Shared Goals

  • Click here to read the full report

All Publications

Research Papers

Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience
Extemporaneously compounded liquid formulations of clofazimine
All Papers

For the Press

Press Contact:
Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

View the 2022 Annual Report

Navigate

  • About
  • Why New TB Drugs?
  • R&D
  • Access
  • News
  • Donate

New York: 80 Pine Street, 20th floor, New York, NY 10005 • +1 212 227 7540

Pretoria: Boardwalk Office Park, Block 1/Suite 5, 107 Haymeadow Street, Faerie Glen, Pretoria 0043, South Africa • +27 12 991 6328

Visit our South Africa website
Press Inquiries

Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

Jobs

View job openings

Join our mailing list
Interests
© 2023 The TB Alliance. All Rights Reserved. Site by Darby Communications Report a Concern